Angelika Eggert
Ärztin
Geboren:
1967
Hat mitgewirkt an:
-
Präparation und Charakterisierung Adenovirus Typ 12-spezifischer polyklonaler Antikörper, gerichtet gegen spezifische E1A-Tumorantigene
-
GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway
-
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
-
A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization